Jpmorgan Chase & CO Entrada Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 133,878 shares of TRDA stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,878
Previous 133,878 -0.0%
Holding current value
$1.13 Million
Previous $776,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$5.02 - $7.57 $598,243 - $902,132
119,172 Added 810.36%
133,878 $776,000
Q1 2025

May 12, 2025
SELL
$9.04 - $18.31 $187,706 - $380,188
-20,764 Reduced 58.54%
14,706 $132,000
Q4 2024

Feb 12, 2025
BUY
$15.82 - $21.59 $390,089 - $532,366
24,658 Added 228.06%
35,470 $613,000
Q3 2024

Dec 26, 2024
BUY
$13.65 - $17.86 $3,303 - $4,322
242 Added 2.29%
10,812 $172,000
Q3 2024

Nov 08, 2024
BUY
$13.65 - $17.86 $3,303 - $4,322
242 Added 2.29%
10,812 $172,000
Q2 2024

Dec 26, 2024
SELL
$11.85 - $16.45 $2,867 - $3,980
-242 Reduced 2.24%
10,570 $150,000
Q2 2024

Aug 12, 2024
BUY
$11.85 - $16.45 $25,560 - $35,482
2,157 Added 25.64%
10,570 $150,000
Q1 2024

Dec 26, 2024
SELL
$11.58 - $17.0 $27,780 - $40,783
-2,399 Reduced 22.19%
8,413 $119,000
Q1 2024

May 10, 2024
SELL
$11.58 - $17.0 $66,480 - $97,597
-5,741 Reduced 40.56%
8,413 $119,000
Q4 2023

Dec 26, 2024
BUY
$11.36 - $16.99 $37,965 - $56,780
3,342 Added 30.91%
14,154 $213,000
Q4 2023

Feb 12, 2024
SELL
$11.36 - $16.99 $4,850 - $7,254
-427 Reduced 2.93%
14,154 $213,000
Q3 2023

Nov 14, 2023
SELL
$13.61 - $18.01 $28,159 - $37,262
-2,069 Reduced 12.43%
14,581 $230,000
Q2 2023

Aug 11, 2023
BUY
$11.02 - $18.01 $89,372 - $146,061
8,110 Added 94.96%
16,650 $252,000
Q1 2023

May 18, 2023
BUY
$9.58 - $16.2 $80,347 - $135,869
8,387 Added 5481.7%
8,540 $123,000
Q1 2023

May 11, 2023
SELL
$9.58 - $16.2 $71,275 - $120,528
-7,440 Reduced 97.98%
153 $2,000
Q4 2022

Feb 13, 2023
BUY
$13.52 - $22.89 $102,657 - $173,803
7,593 New
7,593 $103,000
Q2 2022

Aug 11, 2022
SELL
$5.49 - $12.94 $27,087 - $63,845
-4,934 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$7.99 - $16.93 $11,505 - $24,379
1,440 Added 41.21%
4,934 $46,000
Q4 2021

Feb 10, 2022
BUY
$13.7 - $35.0 $47,867 - $122,290
3,494 New
3,494 $60,000

Others Institutions Holding TRDA

# of Institutions
117
Shares Held
27.9M
Call Options Held
13.7K
Put Options Held
14K
View Full List

About Entrada Therapeutics, Inc.

TRDA Quotes by TradingView
  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $266M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email